COLLEEN VACCARO: Open Payments
NPI 1801987284 · NORTH TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$47,028 in 274 payments from 17 companies in 2025. Trend: 2023 $55,001 · 2024 $58,652 · 2025 $47,028
Speaker / faculty: $36,212Food & beverage: $4,833Travel & lodging: $4,829Consulting: $1,155
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 71 | $23,707 |
| ABBVIE INC. | 43 | $7,136 |
| Regeneron Healthcare Solutions, Inc. | 16 | $4,812 |
| GENZYME CORPORATION | 12 | $4,706 |
| Galderma Laboratories, L.P. | 17 | $3,572 |
| E.R. Squibb & Sons, L.L.C. | 10 | $1,292 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $361 |
| Novartis Pharmaceuticals Corporation | 36 | $350 |
| Janssen Biotech, Inc. | 14 | $288 |
| PFIZER INC. | 12 | $253 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, RINVOQ, TREMFYA, COSENTYX, CIBINQO, Winlevi.
Industry payments across NY — which companies pay providers there.
